Merrimack Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Mar 8 05:46
Merrimack Pharmaceuticals | EFFECT: Others
Jan 8, 2018 13:15
No Data